Sign In
Buy ARWR
$82.00
+0.180 (+0.220%)
At Close: Jun 22, 2026
Arrowhead Pharmaceuticals Could Be A Quick And Easy Double Up From Here
11:08am, Monday, 17'th Aug 2020
BioBoyScout recently raised his price target on Arrowhead Pharmaceuticals to $107. Johnson & Johnson partnership makes up the bulk of Arrowhead's valuation as they expand their partnership to addition
Arrowhead Pharmaceuticals Initiates Dosing Phase 1/2 Study of ARO-ENaC for Treatment of Cystic Fibrosis
11:30am, Tuesday, 11'th Aug 2020
Arrowhead Pharmaceuticals Initiates Dosing Phase 1/2 Study of ARO-ENaC for Treatment of Cystic Fibrosis
Arrowhead Pharmaceuticals: Now The Best Biotech Stock With Near-Term Capital Gain Prospects (NASDAQ:ARWR)
01:02am, Tuesday, 11'th Aug 2020
Most Medical Development & Treatment companies tend not to be involved in the Covid-19 virus vaccine race.
Arrowhead Pharmaceuticals Initiates Dosing Phase 1/2 Study of ARO-ENaC for Treatment of Cystic Fibrosis
12:00am, Tuesday, 11'th Aug 2020
Arrowhead Pharmaceuticals Initiates Dosing Phase 1/2 Study of ARO-ENaC for Treatment of Cystic Fibrosis
ARWR: Biopsy Data from ARO-AAT Trial Before Year End 2020…
11:15am, Monday, 10'th Aug 2020
By David Bautz, PhD NASDAQ:ARWR READ THE FULL ARWR RESEARCH REPORT Business Update Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) is developing medicines that cause gene silencing using RNA interference
Arrowhead Pharmaceuticals Reports Fiscal 2020 Third Quarter Results
08:00pm, Wednesday, 05'th Aug 2020
Arrowhead Pharmaceuticals reports fiscal Q3 2020 earnings results and hosts conference call
The Daily Biotech Pulse: Novavax Vaccine Data, Aerpio Gets $5.1M Funding For COVID Trial, Rigel Gains Big On Earnings
12:00am, Wednesday, 05'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 4)
ABIOMED, Inc. (NASDAQ: ABMD) (FDA approved the emergency use of Abiomed's Impella heart pump in combination...
Charting a solid August start: S&P 500, Nasdaq stage latest summer breakouts
04:38pm, Tuesday, 04'th Aug 2020
Technically speaking, the U.S. benchmarks’ bigger-picture backdrop remains bullish amid a solid August start, writes Michael Ashbaugh.
Absa ARO Completes Fully Virtual Implementation as It Moves to Fiserv for Card Management and Processing Across Nine African Nations
12:00am, Tuesday, 04'th Aug 2020
Absa Regional Operations (ARO) has moved to Fiserv to support credit card management and processing in nine African nations.
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
3 “Perfect 10” Stocks To Consider During Uncertain Times
12:00am, Thursday, 30'th Jul 2020
Stocks Analysis by Investing Insights covering: Arrowhead Pharmaceuticals Inc, LKQ Corporation, Dropbox Inc. Read Investing Insights 's latest article on Investing.com
Arrowhead Pharmaceuticals (ARWR) Presents At ARO-ENaC KOL Webinar - Slideshow
03:41pm, Wednesday, 29'th Jul 2020
The following slide deck was published by Arrowhead Pharmaceuticals, Inc. in conjunction with this event..
Arrowhead Pharmaceuticals Earns $20 Million Milestone Payment from Amgen for Start of Phase 2 Trial of AMG 890
11:30am, Wednesday, 29'th Jul 2020
Amgen pays Arrowhead $20 million milestone for start of Phase 2 study of AMG 890 formerly ARO-LPA
3 “Perfect 10” Stocks to Snap Up Now
11:08pm, Tuesday, 28'th Jul 2020
Wall Street is sending mixed signals. While the S&P 500 is up 45% from its March lows, the market was choppy throughout most of June and July. On top of this, new COVID-19 cases are being reported at
Charting a (bullish) holding pattern, S&P 500 digests break to 5-month highs
04:44pm, Tuesday, 28'th Jul 2020
The major U.S. benchmarks are acting well technically, though amid increasingly sideways late-July price action, writes Michael Ashbaugh.
